Emerging Transplant Infections 2021
DOI: 10.1007/978-3-030-25869-6_43
|View full text |Cite
|
Sign up to set email alerts
|

Candida Infections in Solid Organ Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 149 publications
0
5
0
Order By: Relevance
“…This may help to limit the spread of the infection and promote the clearance of infected cells. In solid organ transplant patients, the immune response to C. albicans infection can be further complicated by immunosuppressive drugs, impairing the host's ability to control the infection [22][23][24]. In these patients, necroptosis and apoptosis have been shown to contribute to the development of transplant-related morbidity and mortality and the development of allograft rejection [66][67][68][69][70].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This may help to limit the spread of the infection and promote the clearance of infected cells. In solid organ transplant patients, the immune response to C. albicans infection can be further complicated by immunosuppressive drugs, impairing the host's ability to control the infection [22][23][24]. In these patients, necroptosis and apoptosis have been shown to contribute to the development of transplant-related morbidity and mortality and the development of allograft rejection [66][67][68][69][70].…”
Section: Discussionmentioning
confidence: 99%
“…Solid organ transplant (SOT) patients are at increased risk of developing C. albicans infections as these patients often have weakened immune systems because of the use of immunosuppressive drugs, use of antibiotics, and comorbidities [22][23][24]. Therefore, endothelial and epithelial cells are important for controlling these infections.…”
Section: Introductionmentioning
confidence: 99%
“…Overall, invasive candidiasis remains associated with high rates of morbidity, mortality, and excess healthcare costs [ 24 ]. Mortality at 12 weeks after diagnosis ranges from 20 to 40% and appears to be particularly high for non- C. albicans infections [ 24 , 25 ].…”
Section: Overview Of the Epidemiology Of Ifis In Sot And Hsctmentioning
confidence: 99%
“…In general, invasive candidiasis is the earliest complication of SOT [ 24 ]. With current antifungal prophylaxis strategies, the time to onset of invasive candidiasis ranges from 2 to 6 months [ 5 , 22 , 25 ]. In heart transplant recipients, invasive candidiasis occurs rapidly in the first 100 days after transplantation, possibly related to the frequent use of catheters in this setting [ 22 ].…”
Section: Timing Of Post-transplant Ifismentioning
confidence: 99%
“…Current guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation (IDCOP/AST) recommends antifungal prophylaxis in patients with enteric drainage, postperfusion pancreatitis, and vascular thrombosis [ 11 ]. However, the use of antifungal medications, particularly the use of azoles, are not without risk as they can cause significant hepatotoxicity, may lead to important drug–drug interactions (particularly with calcineurin inhibitors), and can facilitate the emergence of azole-resistant Candida spp [ 12 ].…”
mentioning
confidence: 99%